TABLE 2.
HIV-1 gene region(s) | Result for infants aged:
|
|||||
---|---|---|---|---|---|---|
48 h
|
1-2 mo
|
3-6 mo
|
||||
Sensitivitya (n = 10) | Specificityb (n = 94) | Sensitivity (n = 12) | Specificity (n = 94) | Sensitivity (n = 16) | Specificity (n = 94) | |
env | 40.0 | 100 | 91.7 | 98.9 | 87.5 | 100 |
gag | 30.0 | 100 | 75.0 | 100 | 75.0 | 100 |
pol | 50.0 | 100 | 66.7 | 100 | 87.5 | 98.9 |
Three regions combinedc | 30.0 | 100 | 91.7 | 100 | 93.7 | 100 |
Sensitivity is derived from the number of HIV-1-positive infants determined by the N3M-PCR assay divided by the number of HIV-1-positive infants determined by the validation standard.
Specificity is derived from the number of HIV-1-negative infants determined by the N3M-PCR assay divided by the number of HIV-1-positive infants determined by the validation standard.
Combined results from all three regions were interpreted as follows: (i) if more than two regions of the pol, gag, and env genes were positive, the samples were determined to be HIV-1 positive; (ii) if only one region was positive, the results were reported as indeterminate for HIV-1; moreover, HIV-1 DNA samples determined to be indeterminate or positive were retested by the N3M-PCR assay; (iii) if none of the three regions was amplified, the samples were considered HIV-1 negative.